Page last updated: 2024-11-05

zonisamide and Hypokalemia

zonisamide has been researched along with Hypokalemia in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
MacMahon, T1
Kelly, YP1

Other Studies

1 other study available for zonisamide and Hypokalemia

ArticleYear
Zonisamide-induced distal renal tubular acidosis and critical hypokalaemia.
    BMJ case reports, 2023, Apr-11, Volume: 16, Issue:4

    Topics: Acidosis; Acidosis, Renal Tubular; Female; Humans; Hypokalemia; Muscle Weakness; Zonisamide

2023